Interleukin-32 gamma specific monoclonal antibody and developing IL-32 specific ELISA

Hybridoma

Volumn 29, Issue 6, 2010, Pages 501-509

  Lee, Siyoung ^a,b   Kim, Sunjong ^c   Bae, Suyoung ^b   Choi, Jida ^b   Hong, Jaewoo ^b   Ryoo, Soyoon ^b   Jhun, Hyunjhung ^b   Hong, Kwangwon ^b   Kim, Eunsom ^b   Jo, Seunghyun ^b   Her, Erk ^a   Kim, Soohyun ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c Konkuk University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 32; INTERLEUKIN 32 GAMMA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A11 C9; MONOCLONAL ANTIBODY A7 B1; MONOCLONAL ANTIBODY D9 F11; MONOCLONAL ANTIBODY E1 H7; MONOCLONAL ANTIBODY H7 C5; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOTIN; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; IMMUNOASSAY; IMMUNOPRECIPITATION; INTERLEUKINS; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS; RECOMBINANT PROTEINS;

ESCHERICHIA COLI; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA A VIRUS; MUS MUSCULUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 78650092827     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0059     Document Type: Article

References (21)

1. Dahl CA, Schall RP, He HL, and Cairns JS: Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992;148:597-603.
2. Dinarello CA, and Kim SH: IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006;65 (Suppl 3): Iii61-64. (Pubitemid 44629106)
3. Kim SH, Han SY, Azam T, Yoon DY, and Dinarello CA: Interleukin-32: A cytokine and inducer of TNFalpha. Immunity 2005;22:131-142.
4. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim- Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, and Andoh A: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007;149: 480-486. (Pubitemid 47256156)
5. Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, and Chiocchia G: Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Net 2005;16:289-292. (Pubitemid 350056544)
6. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers- Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, and van den Berg WB: IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006;103:3298-3303. (Pubitemid 43346464)
7. Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, Kochi Y, and Yamamoto K: Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006;8: R166.
8. Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, and Kim SH: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005;102:16309-16314. (Pubitemid 41688910)
9. Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY, Dinarello CA, and Kim SH: Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA 2008;105:3515-3520. (Pubitemid 351723584)
10. Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, and Dinarello CA: Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/ interferon-gamma-dependent mechanism. PLoS Med 2006; 3:e277.
11. Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello CA, and Saetta M: IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178: 894-901.
12. Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA, and Deeg HJ: Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci USA 2008;105:2865-2870. (Pubitemid 351723635)
13. Rasool ST, Tang H, Wu J, Li W, Mukhtar MM, Zhang J, Mu Y, Xing HX, Wu J, and Zhu Y: Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett 2008;117:161-167.
14. Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J, and Zhu Y: Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 2008; 3:e1985.
15. Ko NY, Chang SH, Lee JH, Kim NW, Kim YM, Choi WS, Choi JD, Bae SY, Hong JW, Jaekal J, Azam T, Her E, and Kim SH: Unique expression of a small IL-32 protein in the Jurkat leukemic T cell line. Cytokine 2008;42:121-127.
16. Van Belle T, and Grooten J: IL-15 and IL-15Ralpha in CD4+T cell immunity. Arch Immunol Ther Exp (Warsz) 2005;53:115-126. (Pubitemid 41057861)
17. Wyzgol A, Muller N, Fick A, Munkel S, Grigoleit GU, Pfizenmaier K, and Wajant H: Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand. J Immunol 2009;183:1851-1861.
18. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, and Dinarello CA: Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 2008;181:557-565.
19. Kobayashi H, and Lin PC: Molecular characterization of IL-32 in human endothelial cells. Cytokine 2009;46:351-358.
20. Seo EH, Kang J, Kim KH, Cho MC, Lee S, Kim HJ, Kim JH, Kim EJ, Park DK, Kim SH, Choi YK, Kim JM, Hong JT, and Yoon DY: Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 2008;18:1606-1612.
21. Kim KH, Shim JH, Seo EH, Cho MC, Kang JW, Kim SH, Yu DY, Song EY, Lee HG, Sohn JH, Kim J, Dinarello CA, and Yoon DY: Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA. J Immunol Methods 2008;333:38-50.